Finora Dosage/Direction for Use

Dosage: Adults: The recommended dose is 200 mg daily administered as one capsule of Fenofibrate 200 mg capsules.
The dose can be titrated up to 267 mg daily administered as 4 capsules of Fenofibrate 67 mg capsules, if required. This maximum dose is not recommended in addition to a statin.
Special populations: Elderly patients (≥65 years old): No dose adjustment is necessary. The usual dose is recommended, except for decreased renal function with estimated glomerular filtration rate <60 mL/min/1.73 m2 (see Patients with renal impairment as follows).
Patients with renal impairment: Fenofibrate should not be used if severe renal impairment, defined as eGFR <30 mL/min per 1.73 m2, is present.
If eGFR is between 30 and 59 mL/min per 1.73 m2, the dose of fenofibrate should not exceed 100 mg standard or 67 mg micronized once daily.
If, during follow-up, the eGFR decreases persistently to <30 mL/min per 1.73 m2, fenofibrate should be discontinued.
Hepatic impairment: Fenofibrate 200 mg capsules are is not recommended for use in patients with hepatic impairment due to the lack of data.
Paediatric population: The safety and efficacy of fenofibrate in children and adolescents younger than 18 years has not been established. No data are available.
Therefore, the use of fenofibrate is not recommended in pediatric subjects under 18 years.
Method of administration: Capsules should be swallowed whole during a meal.